Michael F. Wempe
- Biochemistry top 0.2%
- Amino Acid Enzymes and Metabolism 21
- Pharmaceutical Science top 0.5%
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders 11
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 17
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 14
- Histone Deacetylase Inhibitors Research 8
- Polyamine Metabolism and Applications 6
-
- HIV/AIDS drug development and treatment 7
-
- Estrogen and related hormone effects 6
- Co-authors
- Hitoshi EndouKevin J. EdgarYoshikatsu KanaiChristiane BaldesEva-Maria CollnotClaus‐Michael LehrUlrich F. SchaeferCharles Buchanan
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Michael F. Wempe
129 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 129
- Biochemistry 981
- Pharmaceutical Science 518
- Clinical Biochemistry 383
- Oncology 952
- Molecular Biology 2.2k
Countries citing papers authored by Michael F. Wempe
This map shows the geographic impact of Michael F. Wempe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Wempe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Wempe more than expected).
Fields of papers citing papers by Michael F. Wempe
This network shows the impact of papers produced by Michael F. Wempe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Wempe. The network helps show where Michael F. Wempe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael F. Wempe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 26 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 9 | |
| 10 | 2019 | 37 | |
| 11 | 2019 | 19 | |
| 12 | Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes. | 2017 | 2 |
| 13 | 2016 | 140 | |
| 14 | 2015 | 2 | |
| 15 | 2015 | 16 | |
| 16 | 2014 | 56 | |
| 17 | 2014 | 33 | |
| 18 | 2014 | 10 | |
| 19 | 2011 | 1 | |
| 20 | 2008 | 65 |
About Michael F. Wempe
Michael F. Wempe is a scholar working on Biochemistry, Clinical Biochemistry and Pharmaceutical Science, having authored 133 papers that have together received 4.9k indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (21 papers), Drug Transport and Resistance Mechanisms (17 papers), Epigenetics and DNA Methylation (14 papers), Metabolism and Genetic Disorders (11 papers), Histone Deacetylase Inhibitors Research (8 papers), HIV/AIDS drug development and treatment (7 papers), Estrogen and related hormone effects (6 papers) and Polyamine Metabolism and Applications (6 papers). The work is most often cited by research in Biochemistry (981 citations), Pharmaceutical Science (518 citations) and Clinical Biochemistry (383 citations). Michael F. Wempe has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Hitoshi Endou, Kevin J. Edgar, Yoshikatsu Kanai, Christiane Baldes, Eva-Maria Collnot, Claus‐Michael Lehr, Ulrich F. Schaefer, Charles Buchanan, Julian Little and Naohiko Anzai. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.